Tapewire

Nasdaq · USD

BMRN

BIOMARIN PHARMACEUTICAL INC

Export transactions ↓
Tapewire entity
2404
SEC CIK
0001048477
Parsed reports
685

Last 12 months

Inside the activity.

0 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202601
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 12, 2019 Filed Mar 14, 2019 00:00 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 4,000 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001567619-19-006805 · doc1.xml · derivative · entry 7

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 4,000 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2018.

F4 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
March 12, 2019 Filed Mar 14, 2019 00:00 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 4,000 $91.44 $365,770.40
Disclosure

SEC source: 0001567619-19-006805 · doc1.xml · nonDerivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,701

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2018.

F3 · price: The price in column 4 is the weighted average price. The price actually received ranged from $91.22 to $91.77. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
March 12, 2019 Filed Mar 14, 2019 00:00 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 4,000 $14.39 $57,560.00
Disclosure

SEC source: 0001567619-19-006805 · doc1.xml · nonDerivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 332,701

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2018.

Read SEC document
March 11, 2019 Filed Mar 14, 2019 00:00 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 5,000 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001567619-19-006805 · doc1.xml · derivative · entry 6

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,000

Underlying: Common Stock · 5,000 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2018.

F4 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
March 11, 2019 Filed Mar 14, 2019 00:00 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 5,000 $88.96 $444,779.50
Disclosure

SEC source: 0001567619-19-006805 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,701

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2018.

F2 · price: The price in column 4 is the weighted average price. The price actually received ranged from $88.70 to $89.11. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
March 11, 2019 Filed Mar 14, 2019 00:00 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 5,000 $14.39 $71,950.00
Disclosure

SEC source: 0001567619-19-006805 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 333,701

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2018.

Read SEC document
March 07, 2019 Filed Mar 9, 2019 01:34 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 4,000 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001567619-19-006530 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,000

Underlying: Common Stock · 4,000 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
March 07, 2019 Filed Mar 9, 2019 01:34 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 4,000 $90.78 $363,120.00
Disclosure

SEC source: 0001567619-19-006530 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,701

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

Read SEC document
March 07, 2019 Filed Mar 9, 2019 01:34 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 4,000 $14.39 $57,560.00
Disclosure

SEC source: 0001567619-19-006530 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 332,701

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

Read SEC document
March 04, 2019 Filed Mar 6, 2019 22:45 UTC
FUCHS HENRY JPresident, Worldwide R&D
SaleCommon Stock 2,196 $95.00 $208,620.00
Disclosure

SEC source: 0001567619-19-006317 · doc1.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,504

F1 · date: Trade made pursuant to a 10b5-1 plan executed on October 30, 2018.

Read SEC document
March 01, 2019 Filed Mar 6, 2019 00:58 UTC
FUCHS HENRY JPresident, Worldwide R&D
Tax withholdingCommon Stock 1,154 $94.76 $109,353.04
Disclosure

SEC source: 0001567619-19-006238 · doc1.xml · nonDerivative · entry 2

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,700

Read SEC document
March 01, 2019 Filed Mar 6, 2019 00:58 UTC
FUCHS HENRY JPresident, Worldwide R&D
GrantCommon Stock 15,687 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-006238 · doc1.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,854

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2018 as set forth in the Issuer's audited financial statements.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 15, 2019, 2020 and 2021, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events.

Read SEC document
March 01, 2019 Filed Mar 6, 2019 00:37 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
Tax withholdingCommon Stock 917 $94.76 $86,894.92
Disclosure

SEC source: 0001567619-19-006234 · doc1.xml · nonDerivative · entry 2

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,775

Read SEC document
March 01, 2019 Filed Mar 6, 2019 00:37 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
GrantCommon Stock 12,557 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-006234 · doc1.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,692

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2018 as set forth in the Issuer's audited financial statements.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 15, 2019, 2020 and 2021, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events.

Read SEC document
March 01, 2019 Filed Mar 6, 2019 00:16 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Tax withholdingCommon Stock 4,909 $94.76 $465,176.84
Disclosure

SEC source: 0001567619-19-006229 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,701

Read SEC document
March 01, 2019 Filed Mar 6, 2019 00:16 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
GrantCommon Stock 45,320 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-006229 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 333,610

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2018 as set forth in the Issuer's audited financial statements.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 15, 2019, 2020 and 2021, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events.

Read SEC document
March 01, 2019 Filed Mar 6, 2019 01:08 UTC
SPIEGELMAN DANIEL KEVP, Chief Financial Officer
Tax withholdingCommon Stock 912 $94.76 $86,421.12
Disclosure

SEC source: 0001567619-19-006240 · doc1.xml · nonDerivative · entry 2

SPIEGELMAN DANIEL K · CIK 0001238403 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,538

Read SEC document
March 01, 2019 Filed Mar 6, 2019 01:08 UTC
SPIEGELMAN DANIEL KEVP, Chief Financial Officer
GrantCommon Stock 12,205 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-006240 · doc1.xml · nonDerivative · entry 1

SPIEGELMAN DANIEL K · CIK 0001238403 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,450

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2018 as set forth in the Issuer's audited financial statements.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 15, 2019, 2020 and 2021, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events.

Read SEC document
March 01, 2019 Filed Mar 6, 2019 00:47 UTC
Davis George EricEVP, General Counsel
Tax withholdingCommon Stock 840 $94.76 $79,598.40
Disclosure

SEC source: 0001567619-19-006236 · doc1.xml · nonDerivative · entry 2

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,747

Read SEC document
March 01, 2019 Filed Mar 6, 2019 00:47 UTC
Davis George EricEVP, General Counsel
GrantCommon Stock 11,853 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-006236 · doc1.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,587

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2018 as set forth in the Issuer's audited financial statements.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 15, 2019, 2020 and 2021, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events.

Read SEC document
March 01, 2019 Filed Mar 6, 2019 00:28 UTC
BAFFI ROBERTEVP, Technical Operations
Tax withholdingCommon Stock 917 $94.76 $86,894.92
Disclosure

SEC source: 0001567619-19-006231 · doc1.xml · nonDerivative · entry 2

BAFFI ROBERT · CIK 0001274826 · EVP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,212

Read SEC document
March 01, 2019 Filed Mar 6, 2019 00:28 UTC
BAFFI ROBERTEVP, Technical Operations
GrantCommon Stock 11,853 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-006231 · doc1.xml · nonDerivative · entry 1

BAFFI ROBERT · CIK 0001274826 · EVP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,129

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2018 as set forth in the Issuer's audited financial statements.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 15, 2019, 2020 and 2021, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events.

Read SEC document
February 27, 2019 Filed Mar 1, 2019 01:24 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 4,000 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001567619-19-005682 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,000

Underlying: Common Stock · 4,000 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
February 27, 2019 Filed Mar 1, 2019 01:24 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 4,000 $91.78 $367,120.00
Disclosure

SEC source: 0001567619-19-005682 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 288,290

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

Read SEC document
February 27, 2019 Filed Mar 1, 2019 01:24 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 4,000 $14.39 $57,560.00
Disclosure

SEC source: 0001567619-19-005682 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,290

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

Read SEC document
February 21, 2019 Filed Feb 22, 2019 23:24 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 3,000 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001567619-19-005293 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,000

Underlying: Common Stock · 3,000 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
February 21, 2019 Filed Feb 22, 2019 23:24 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 3,000 $90.12 $270,360.00
Disclosure

SEC source: 0001567619-19-005293 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 288,290

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

Read SEC document
February 21, 2019 Filed Feb 22, 2019 23:24 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 3,000 $14.39 $43,170.00
Disclosure

SEC source: 0001567619-19-005293 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 291,290

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

Read SEC document
February 14, 2019 Filed Feb 16, 2019 00:06 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 4,000 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001567619-19-004695 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 4,000 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
February 14, 2019 Filed Feb 16, 2019 00:06 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 4,000 $95.20 $380,800.00
Disclosure

SEC source: 0001567619-19-004695 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 288,290

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

Read SEC document
February 14, 2019 Filed Feb 16, 2019 00:06 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 4,000 $14.39 $57,560.00
Disclosure

SEC source: 0001567619-19-004695 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,290

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

Read SEC document
February 05, 2019 Filed Feb 8, 2019 00:21 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 4,000 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001567619-19-002679 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,000

Underlying: Common Stock · 4,000 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
February 05, 2019 Filed Feb 8, 2019 00:21 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 4,000 $98.63 $394,520.00
Disclosure

SEC source: 0001567619-19-002679 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 288,290

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

Read SEC document
February 05, 2019 Filed Feb 8, 2019 00:21 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 4,000 $14.39 $57,560.00
Disclosure

SEC source: 0001567619-19-002679 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,290

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

Read SEC document
January 22, 2019 Filed Jan 25, 2019 00:07 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 3,000 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001567619-19-001607 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,000

Underlying: Common Stock · 3,000 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
January 22, 2019 Filed Jan 25, 2019 00:07 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 3,000 $96.82 $290,460.00
Disclosure

SEC source: 0001567619-19-001607 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 288,290

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

Read SEC document
January 22, 2019 Filed Jan 25, 2019 00:07 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 3,000 $14.39 $43,170.00
Disclosure

SEC source: 0001567619-19-001607 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 291,290

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

Read SEC document
January 14, 2019 Filed Jan 16, 2019 00:43 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 4,000 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001567619-19-001176 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,000

Underlying: Common Stock · 4,000 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
January 14, 2019 Filed Jan 16, 2019 00:43 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 4,000 $93.79 $375,160.00
Disclosure

SEC source: 0001567619-19-001176 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 288,290

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

Read SEC document
January 14, 2019 Filed Jan 16, 2019 00:43 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 4,000 $14.39 $57,560.00
Disclosure

SEC source: 0001567619-19-001176 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,290

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

Read SEC document
January 10, 2019 Filed Jan 11, 2019 20:30 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 3,000 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001567619-19-001029 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 3,000 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
January 10, 2019 Filed Jan 11, 2019 20:30 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 3,000 $90.55 $271,650.00
Disclosure

SEC source: 0001567619-19-001029 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 288,290

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

Read SEC document
January 10, 2019 Filed Jan 11, 2019 20:30 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 3,000 $14.39 $43,170.00
Disclosure

SEC source: 0001567619-19-001029 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 291,290

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

Read SEC document
January 08, 2019 Filed Jan 10, 2019 23:50 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 6,000 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001567619-19-000988 · doc1.xml · derivative · entry 6

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,000

Underlying: Common Stock · 6,000 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2018.

F5 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
January 08, 2019 Filed Jan 10, 2019 23:50 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 3,401 $91.73 $311,990.05
Disclosure

SEC source: 0001567619-19-000988 · doc1.xml · nonDerivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 288,290

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2018.

F4 · price: The price in column 4 is the weighted average price. The price actually received ranged from $91.61 to $92.22. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
January 08, 2019 Filed Jan 10, 2019 23:50 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 1,599 $91.55 $146,388.45
Disclosure

SEC source: 0001567619-19-000988 · doc1.xml · nonDerivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 291,691

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2018.

F3 · price: The price in column 4 is the weighted average price. The price actually received ranged from $91.51 to $91.60. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
January 08, 2019 Filed Jan 10, 2019 23:50 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 1,000 $91.14 $91,144.00
Disclosure

SEC source: 0001567619-19-000988 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 293,290

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2018.

F2 · price: The price in column 4 is the weighted average price. The price actually received ranged from $90.51 to $91.45. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
January 08, 2019 Filed Jan 10, 2019 23:50 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 6,000 $14.39 $86,340.00
Disclosure

SEC source: 0001567619-19-000988 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 294,290

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2018.

Read SEC document
January 07, 2019 Filed Jan 9, 2019 19:55 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 3,000 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001567619-19-000878 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,000

Underlying: Common Stock · 3,000 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
January 07, 2019 Filed Jan 9, 2019 19:55 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 3,000 $87.58 $262,740.00
Disclosure

SEC source: 0001567619-19-000878 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 288,290

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.